BNP Paribas Financial Markets
TSBX

BNP Paribas Financial Markets’s Turnstone Biologics TSBX Stock Holding History

BNP Paribas Financial Markets’s Portfolio TSBX Stock Details TSBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-121
Closed -$43 – 5780
2025
Q2 		$43 Hold
121
– – ﹤0.01% 5364
2025
Q1 		$50 Sell
121
-15,117
-99% -$6.43K ﹤0.01% 5292
2024
Q4 		$7.57K Buy
+15,238
New +$7.53K ﹤0.01% 4881

BNP Paribas Financial Markets's TSBX Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of Turnstone Biologics (TSBX) in Q3 2025, closing a stake of 121 shares — an estimated $43 sold.

BNP Paribas Financial Markets first reported a position in TSBX in Q4 2024 and held it in 3 quarters. The position peaked at $7.57K in Q4 2024. 1 fund tracked by Wall St. Rank holds TSBX as of Q3 2025.

  • BNP Paribas Financial Markets reported no remaining Turnstone Biologics position as of Q3 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 121 Turnstone Biologics shares in Q3 2025, an estimated $43.
  • BNP Paribas Financial Markets first reported a position in Turnstone Biologics in Q4 2024 and held it in 3 quarters.
  • BNP Paribas Financial Markets's Turnstone Biologics position peaked at $7.57K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Turnstone Biologics as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.